{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:06:42Z","timestamp":1789672002113,"version":"4.0.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.bbrc.2019.08.115","type":"journal-article","created":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T16:11:36Z","timestamp":1567267896000},"page":"41-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Artesunate promotes sensitivity to sorafenib in hepatocellular carcinoma"],"prefix":"10.1016","volume":"519","author":[{"given":"Wu","family":"Jing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Shuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Yingru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Runpeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xie","family":"Jun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8995-4729","authenticated-orcid":false,"given":"Hu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2019.08.115_bib1","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2174\/092986712799320736","article-title":"Sorafenib (BAY 43-9006) in hepatocellular carcinoma patients: from discovery to clinical development","volume":"19","author":"Ranieri","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbrc.2019.08.115_bib2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12935-018-0538-7","article-title":"Resistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight","volume":"18","author":"Lohitesh","year":"2018","journal-title":"Cancer Cell Int."},{"issue":"Suppl 1","key":"10.1016\/j.bbrc.2019.08.115_bib3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1478-3231.2010.02395.x","article-title":"Novel molecular therapies in hepatocellular carcinoma","volume":"31","author":"Faivre","year":"2011","journal-title":"Liver Int."},{"key":"10.1016\/j.bbrc.2019.08.115_bib4","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1136\/gutjnl-2013-304564","article-title":"Hepatocellular carcinoma and sorafenib: too many resistance mechanisms?","volume":"62","author":"Berasain","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.bbrc.2019.08.115_bib5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1155\/2015\/736159","article-title":"Artesunate treatment of severe pediatric malaria: a review of parasite clearance kinetics and clinical implications","volume":"26","author":"Hawkes","year":"2015","journal-title":"Can. J. Infect Dis. Med. Microbiol."},{"key":"10.1016\/j.bbrc.2019.08.115_bib6","doi-asserted-by":"crossref","first-page":"6026","DOI":"10.1002\/jcb.27889","article-title":"Dependence of artesunate on long noncoding RNA-RP11 to inhibit epithelial-mesenchymal transition of hepatocellular carcinoma","volume":"120","author":"Jing","year":"2019","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.bbrc.2019.08.115_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.yexmp.2019.01.006","article-title":"The anti-malarial drug artesunate causes cell cycle arrest and apoptosis of triple-negative MDA-MB-468 and HER2-enriched SK-BR-3 breast cancer cells","volume":"107","author":"Greenshields","year":"2019","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.bbrc.2019.08.115_bib8","doi-asserted-by":"crossref","first-page":"988","DOI":"10.2174\/1568009618666180425142653","article-title":"The anti-malarial drug artesunate blocks wnt\/beta-catenin pathway and inhibits growth, migration and invasion of uveal melanoma cells","volume":"18","author":"Zheng","year":"2018","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.bbrc.2019.08.115_bib9","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1002\/jcb.23114","article-title":"Down-regulation of BMI-1 cooperates with artemisinin on growth inhibition of nasopharyngeal carcinoma cells","volume":"112","author":"Wu","year":"2011","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.bbrc.2019.08.115_bib10","first-page":"279","article-title":"Artesunate enhances TRAIL-induced apoptosis in human cervical carcinoma cells through inhibition of the NF-kappaB and PI3K\/Akt signaling pathways","volume":"39","author":"Thanaketpaisarn","year":"2011","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbrc.2019.08.115_bib11","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1158\/1535-7163.MCT-15-0976","article-title":"Single agent and synergistic activity of the \"First-in-Class\" dual PI3K\/BRD4 inhibitor SF1126 with sorafenib in hepatocellular carcinoma","volume":"15","author":"Singh","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbrc.2019.08.115_bib12","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12957-015-0559-9","article-title":"Long-term complete response of advanced hepatocellular carcinoma treated with multidisciplinary therapy including reduced dose of sorafenib: case report and review of the literature","volume":"13","author":"Shinoda","year":"2015","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.bbrc.2019.08.115_bib13","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.3748\/wjg.v24.i36.4152","article-title":"Ten years of sorafenib in hepatocellular carcinoma: are there any predictive and\/or prognostic markers?","volume":"24","author":"Marisi","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbrc.2019.08.115_bib14","first-page":"9377","article-title":"Inhibition of the PI3K\/Akt signaling pathway reverses sorafenib-derived chemo-resistance in hepatocellular carcinoma","volume":"15","author":"Zhang","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbrc.2019.08.115_bib15","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/hep.28357","article-title":"PI3K\/AKT\/mTOR-dependent stabilization of oncogenic far-upstream element binding proteins in hepatocellular carcinoma cells","volume":"63","author":"Samarin","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2019.08.115_bib16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41420-019-0165-7","article-title":"The PI3K inhibitor copanlisib synergizes with sorafenib to induce cell death in hepatocellular carcinoma","volume":"5","author":"Ye","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2019.08.115_bib17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/lt.22434","article-title":"Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation","volume":"18","author":"Gomez-Martin","year":"2012","journal-title":"Liver Transplant."},{"key":"10.1016\/j.bbrc.2019.08.115_bib18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bbrc.2016.06.042","article-title":"ESAT6 inhibits autophagy flux and promotes BCG proliferation through MTOR","volume":"477","author":"Dong","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2019.08.115_bib19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.bbrc.2015.04.051","article-title":"Autophagy regulation revealed by SapM-induced block of autophagosome-lysosome fusion via binding RAB7","volume":"461","author":"Hu","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2019.08.115_bib20","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/j.vaccine.2014.02.069","article-title":"Autophagy-targeted vaccine of LC3-LpqH DNA and its protective immunity in a murine model of tuberculosis","volume":"32","author":"Hu","year":"2014","journal-title":"Vaccine"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X19316444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X19316444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:40:41Z","timestamp":1757763641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X19316444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0006291X19316444"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.08.115","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artesunate promotes sensitivity to sorafenib in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.08.115","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}